These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19967433)

  • 1. Sample size/power calculations for repeated ordinal measurements in population pharmacodynamic experiments.
    Ogungbenro K; Aarons L
    J Pharmacokinet Pharmacodyn; 2010 Feb; 37(1):67-83. PubMed ID: 19967433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sample size calculations for population pharmacodynamic experiments involving repeated dichotomous observations.
    Ogungbenro K; Aarons L
    J Biopharm Stat; 2008; 18(6):1212-27. PubMed ID: 18991118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sample size/power calculations for population pharmacodynamic experiments involving repeated-count measurements.
    Ogungbenro K; Aarons L
    J Biopharm Stat; 2010 Sep; 20(5):1026-42. PubMed ID: 20721789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sample-size calculations for multi-group comparison in population pharmacokinetic experiments.
    Ogungbenro K; Aarons L
    Pharm Stat; 2010; 9(4):255-68. PubMed ID: 19714737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sample size calculations based on generalized estimating equations for population pharmacokinetic experiments.
    Ogungbenro K; Aarons L; Graham G
    J Biopharm Stat; 2006; 16(2):135-50. PubMed ID: 16584063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population Fisher information matrix and optimal design of discrete data responses in population pharmacodynamic experiments.
    Ogungbenro K; Aarons L
    J Pharmacokinet Pharmacodyn; 2011 Aug; 38(4):449-69. PubMed ID: 21660504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sample-size calculations for studies with correlated ordinal outcomes.
    Kim HY; Williamson JM; Lyles CM
    Stat Med; 2005 Oct; 24(19):2977-87. PubMed ID: 16149125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sample size computations for PK/PD population models.
    Kang D; Schwartz JB; Verotta D
    J Pharmacokinet Pharmacodyn; 2005 Dec; 32(5-6):685-701. PubMed ID: 16284914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of pharmacokinetic studies for latent covariates.
    Lagishetty CV; Coulter CV; Duffull SB
    J Pharmacokinet Pharmacodyn; 2012 Feb; 39(1):87-97. PubMed ID: 22161222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid sample size calculations for a defined likelihood ratio test-based power in mixed-effects models.
    Vong C; Bergstrand M; Nyberg J; Karlsson MO
    AAPS J; 2012 Jun; 14(2):176-86. PubMed ID: 22350626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of type I error rates when modeling ordered categorical data in NONMEM.
    Wählby U; Matolcsi K; Karlsson MO; Jonsson EN
    J Pharmacokinet Pharmacodyn; 2004 Feb; 31(1):61-74. PubMed ID: 15346852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statistical power calculations for mixed pharmacokinetic study designs using a population approach.
    Kloprogge F; Simpson JA; Day NP; White NJ; Tarning J
    AAPS J; 2014 Sep; 16(5):1110-8. PubMed ID: 25011414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A survey of population analysis methods and software for complex pharmacokinetic and pharmacodynamic models with examples.
    Bauer RJ; Guzy S; Ng C
    AAPS J; 2007 Mar; 9(1):E60-83. PubMed ID: 17408237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacodynamic model for ketorolac analgesia.
    Mandema JW; Stanski DR
    Clin Pharmacol Ther; 1996 Dec; 60(6):619-35. PubMed ID: 8988064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of GEE procedures for sample size calculations in repeated measures experiments.
    Rochon J
    Stat Med; 1998 Jul; 17(14):1643-58. PubMed ID: 9699236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimates, power and sample size calculations for two-sample ordinal outcomes under before-after study designs.
    Strickland PA; Lu SE
    Stat Med; 2003 Jun; 22(11):1807-18. PubMed ID: 12754716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PFIM 4.0, an extended R program for design evaluation and optimization in nonlinear mixed-effect models.
    Dumont C; Lestini G; Le Nagard H; Mentré F; Comets E; Nguyen TT;
    Comput Methods Programs Biomed; 2018 Mar; 156():217-229. PubMed ID: 29428073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal design for multiresponse pharmacokinetic-pharmacodynamic models - dealing with unbalanced designs.
    Ogungbenro K; Gueorguieva I; Majid O; Graham G; Aarons L
    J Pharmacokinet Pharmacodyn; 2007 Jun; 34(3):313-31. PubMed ID: 17285361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal Joint Modelling of Ordinal and Overdispersed Count Outcomes: A Bridge Distribution for the Ordinal Random Intercept.
    Amini P; Moghimbeigi A; Zayeri F; Tapak L; Maroufizadeh S; Verbeke G
    Comput Math Methods Med; 2021; 2021():5521881. PubMed ID: 33763151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A procedure for generating bootstrap samples for the validation of nonlinear mixed-effects population models.
    Parke J; Holford NH; Charles BG
    Comput Methods Programs Biomed; 1999 Apr; 59(1):19-29. PubMed ID: 10215174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.